XGen Pharmaceuticals DJB
Susan Badia has extensive work experience in the pharmaceutical industry. Susan is currently the Chief Executive Officer of XGen Pharmaceuticals DJB, a position they have held since September 2019. Before that, Susan served as the President of X-GEN Pharmaceuticals Inc. from June 2003 onward. Prior to their role at X-GEN Pharmaceuticals, they worked at Pharma-Tek Inc. as the Assistant to the President from August 1992 to June 2003.
Susan Badia attended Arizona State University, where they pursued a Bachelor of Science (B.S.) in Political Science and Government. Susan then went on to attend Pepperdine Law, where they obtained a Doctor of Law (JD) degree with a specialization in Banking, Corporate, Finance, and Securities Law.
This person is not in any offices
XGen Pharmaceuticals DJB
Approaching the end of a 20 year career at a major pharmaceutical company, Dan Badia made a discovery. Where larger companies found obsolescence in small markets or low-profit yielding drugs, Dan saw reliable solutions proven to be effective and affordable alternatives for healthcare. With his wife, Shirley Harmening, Dan founded a company in 1973 on a bridge table in his bedroom. In just 14 years, this company would outgrow its birthplace and find a home in lower upstate New York. That growth would be sustained by introducing injectables into an established product line, mainly consisting of anti-infective, compounding powders. In 2003, that company would become X-GEN Pharmaceuticals, Inc. Affirming Dan’s original vision while embracing a dynamic industry, family-owned X-GEN Pharmaceuticals, Inc. remained a leader in generic, anti-infective pharmaceuticals. In this our 50th year in affiliation, we honor this heritage by carrying our founder’s initials in our new name, XGen Pharmaceuticals DJB. With reverence for the past and a passion for the future, we expect big results, driven by bold solutions and delivered by real people.